Author

F. Dundar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Organism:human· 2 Assay:scRNA-seq· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1

Frequent Co-Authors

D. Betel· 3 shared P. Zumbo· 3 shared A. Bosque· 1 shared A. Drilon· 1 shared A. M. Pettinato· 1 shared A. Macedo· 1 shared A. Rubio-Navarro· 1 shared A. Ward· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

D. Betel

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cross-species single-cell comparison of systemic and cardiac inflammatory responses after cardiac injury

E. Cortada, J. Yao, Y. Xia, F. Dundar, P. Zumbo, B. Yang, A. Rubio-Navarro, B. Perder, M. Qiu, A. M. Pettinato, E. A. Homan, L. Stoll, D. Betel, J. Cao, J. Lo

This study compares systemic and cardiac inflammatory responses to injury in mice and zebrafish using single-cell transcriptomics, revealing distinct monocyte/macrophage transcriptional clusters and divergent responses between species.

bioRxiv · Mar 15, 2023 · PreprintCell Biology

Immunogenicity of a public neoantigen derived from mutated PIK3CA

S. S. Chandran, J. Ma, M. G. Klatt, F. Dundar, C. Bandlamudi, P. C. Razavi, H. Y. Wen, B. Weigelt, P. Zumbo, S. N. Fu, L. B. Banks, W. D. Bestman, A. Drilon, D. Betel, D. A. Scheinberg, , C. A. Klebanoff

The paper investigates the immunogenicity of a public neoantigen derived from mutated PIK3CA, showing it is recognized by T cells and presents a framework for immunotherapy.

bioRxiv · Apr 8, 2021 · PreprintImmunology

Selective BCL-XLAntagonists Eliminate Infected Cells from a Primary Cell Model of HIV Latency but not from Ex Vivo Reservoirs

Y. Ren, s. h. huang, A. Macedo, A. Ward, W. Conce, T. Klevorn, L. Leyre, D. Chan, R. Truong, T. Rohwetter, P. Zumbo, F. Dundar, D. Betel, C. Kovacs, E. Benko, , B. Jones

This study shows BCL-XL antagonists reduce HIV in a cell model of latency but not in ex vivo reservoirs, suggesting resistance in true reservoir cells.

bioRxiv · Nov 25, 2020 · PreprintMicrobiology